Managing the risks inherent in nonsterile compounding requires a comprehensive pharmacy compliance program that incorporates established USP 795 standards into daily practice.
A closed-loop solution that supports efforts to comply with USP Chapter 795 is essential for ensuring patient safety and overall quality of medications compounded.